The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Bone marrow mesenchymal stem cells-derived exosomal microRNA-124-3p attenuates hypoxic-ischemic brain damage through depressing tumor necrosis factor receptor associated factor 6 in newborn rats
Abstract
Mesenchymal stem cells (MSCs)-derived exosomes (Exo) are beneficial in the use of brain damages. Restrictively, the mechanism of Exo expressing miR-124-3p in hypoxic-ischemic brain damage (HIBD) is not completely comprehended. Thereupon, this work was put forward to reveal the action of bone marrow MSCs-derived Exo (BMSCs-Exo) expressing miR-124-3p in the illness. BMSCs were isolated and transfected with miR-124-3p agomir. Then, BMSCs-Exo were extracted and identified. The newborn HIBD rats were injected with miR-124-3p-modified BMSCs-Exo or tumor necrosis factor receptor associated factor 6 (TRAF6)-related vectors. Next, neurological functions, neuron pathological and structural damages, oxidative stress and neuronal apoptosis were observed. miR-124-3p and TRAF6 expression was tested, along with their targeting relationship. miR-124-3p was down-regulated, and TRAF6 was up-regulated in newborn HIBD rats. miR-124-3p targeted TRAF6. BMSCs-Exo improved neurological functions, alleviated neuron pathological and structural damages, suppressed oxidative stress and reduced neuronal apoptosis in newborn HIBD rats, whereas BMSCs-Exo-mediated effects were enhanced by restoring miR-124-3p. Silencing TRAF6 attenuated HIBD in newborn rats, but overexpression of TRAF6 reversed the protective role of miR-124-3p-overexpressing BMSCs-Exo. This work makes it comprehensive that up-regulated exosomal miR-124-3p ameliorates HIBD in newborn rats by targeting TRAF6, which replenishes the potential agents for curing HIBD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recently, accumulating evidence has showed that EVs, endogenous lipid membrane vesicles 30–150 nm in diameter that can transport therapeutic drugs (including proteins, lipids, and nucleic acids) and possess biocompatibility, metabolic stability, BBB penetrability, and target specificity, are potential avenues for treating neurological diseases [11–14].”
From Engineered Extracellular Vesicles Loaded with MiR-100-5p Antagonist Selectively Target the Lesioned Region to Promote Recovery from Brain Damage (2025) · cites this paper as [11]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Exosome Mediated Delivery of miR-124 Promotes Neurogenesis after Ischemia
Yang, J., Zhang, X., Chen, X., Wang, L., & Yang, G. (2017) · Molecular Therapy - Nucleic Acids · doi:10.1016/j.omtn.2017.04.010 · Cited by 547
Qi, X., Zhang, J., Yuan, H., Xu, Z., Li, Q., Niu, X., Hu, B., Wang, Y., & Li, X. (2016) · International Journal of Biological Sciences · doi:10.7150/ijbs.14809 · Cited by 535
Self-citationHuang, S., Ge, X., Yu, J., Han, Z., Yin, Z., Li, Y., Chen, F., Wang, H., Zhang, J., & Lei, P. (2018) · The FASEB Journal · doi:10.1096/fj.201700673r · Cited by 388
Liu, X., Zhang, M., Liu, H., Zhu, R., He, H., Zhou, Y., Zhang, Y., Li, C., Liang, D., Zeng, Q., et al. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113700 · Cited by 343
Self-citationOphelders, D. R. M. G., Wolfs, T. G. A. M., Jellema, R. K., Zwanenburg, A., Andriessen, P., Delhaas, T., Ludwig, A.-K., Radtke, S., Peters, V., Janssen, L., et al. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0197 · Cited by 278
Gangadaran, P., Rajendran, R. L., Lee, H. W., Kalimuthu, S., Hong, C. M., Jeong, S. Y., Lee, S.-W., Lee, J., & Ahn, B.-C. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.08.022 · Cited by 210
Li, R., Zhao, K., Ruan, Q., Meng, C., & Yin, F. (2020) · Arthritis Research & Therapy · doi:10.1186/s13075-020-2146-x · Cited by 161
Thomi, G. F., Joerger-Messerli, M. S., Haesler, V., Muri, L., Surbek, D., & Schoeberlein, A. (2019) · Cells · doi:10.3390/cells8080855 · Cited by 133
Zhou, X. J., Chu, X., Yuan, H., Qiu, J., Zhao, C., Xin, D., Li, T., Ma, W., Wang, H., Wang, Z., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108818 · Cited by 115
MicroRNA-132 attenuates cerebral injury by protecting blood-brain-barrier in MCAO mice
Zuo, X., Lu, J., Manaenko, A., Qi, X., Tang, J., Mei, Q., Xia, Y., & Hu, Q. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.03.017 · Cited by 112
Research works printed but not linked: 3
- Yang L, 2020, Histol Histopathol, 35, 929
- Xiao B, 2019, Biol Open, 8, 1
- Zhu L, 2020, Mol Med Rep, 22, 3944
Cited by
Cheng, Y., Gai, C., Zhao, Y., Li, T., Song, Y., Luo, Q., Xin, D., Jiang, Z., Chen, W., Liu, D., et al. (2025) · Neuroscience Bulletin · doi:10.1007/s12264-025-01376-6 · Cited by 5
Metadata
- Authors
- Min, W., Wu, Y., Fang, Y., Hong, B., Dai, D., Zhou, Y., Liu, J., & Li, Q.
- Affiliations
- Changhai Stroke Center, Changhai Hospital, Second Military Medical University, Shanghai China
- Venue
- Bioengineered
- Publisher
- Informa UK Limited
- Published
- 2022-01-22
- Volume
- 13
- Issue
- 2
- Pages
- 3195-3207
- ISSN
- 2165-5979
- 2165-5987
- PMC
- PMC8973938
- Cited by
- 26
- References
- 48
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bone marrow mesenchymal stem cells-derived exosomal microRNA-124-3p attenuates hypoxic-ischemic brain damage through depressing tumor necrosis factor receptor associated factor 6 in newborn rats. https://app.cochat.ai/papers/10.1080/21655979.2021.2016094
- The paper
- Min, W., Wu, Y., Fang, Y., Hong, B., Dai, D., Zhou, Y., Liu, J., & Li, Q. (2022). Bone marrow mesenchymal stem cells-derived exosomal microRNA-124-3p attenuates hypoxic-ischemic brain damage through depressing tumor necrosis factor receptor associated factor 6 in newborn rats. Bioengineered. https://doi.org/10.1080/21655979.2021.2016094
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.